On Friday Genprex (NASDAQ: GNPX) rose 19.50% to $4.29 on the daily volume of 4,207,976 shares. The tremendous surge began since July 20th which shows a rise from $3.10 to $4.33 on July 23rd. What makes GNPX jump higher?
Due to several clinical trials via regular reporting in news wires, GNPX could slowly grow for a period between January 13th and August 14th. Developing a viable technology to beat various cancers would also lead to skyrocketing GNPX price.
Under $5 price lets short term investors spend a good amount of their funds on GNPX. Around 5 clinical trials may surprise the stakeholders soon with their most likely successful results.